JPH0355448B2 - - Google Patents

Info

Publication number
JPH0355448B2
JPH0355448B2 JP56050014A JP5001481A JPH0355448B2 JP H0355448 B2 JPH0355448 B2 JP H0355448B2 JP 56050014 A JP56050014 A JP 56050014A JP 5001481 A JP5001481 A JP 5001481A JP H0355448 B2 JPH0355448 B2 JP H0355448B2
Authority
JP
Japan
Prior art keywords
mice
granulosum
therapeutic agent
strain
avidum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP56050014A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57165319A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS57165319A publication Critical patent/JPS57165319A/ja
Publication of JPH0355448B2 publication Critical patent/JPH0355448B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP56050014A 1980-03-25 1981-04-02 Manufacture of cell-wall or whole cell medicine in tumor radiative or chemical treatment Granted JPS57165319A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3011461A DE3011461C2 (de) 1980-03-25 1980-03-25 Verwendung von Propionibakterien

Publications (2)

Publication Number Publication Date
JPS57165319A JPS57165319A (en) 1982-10-12
JPH0355448B2 true JPH0355448B2 (https=) 1991-08-23

Family

ID=6098254

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56050014A Granted JPS57165319A (en) 1980-03-25 1981-04-02 Manufacture of cell-wall or whole cell medicine in tumor radiative or chemical treatment

Country Status (13)

Country Link
US (1) US4647456A (https=)
JP (1) JPS57165319A (https=)
AT (1) AT371714B (https=)
AU (1) AU548596B2 (https=)
BE (1) BE888770A (https=)
CA (1) CA1197798A (https=)
CH (1) CH661868A5 (https=)
DE (1) DE3011461C2 (https=)
FR (1) FR2505186A1 (https=)
GB (1) GB2098478B (https=)
NL (1) NL189947C (https=)
NO (1) NO162079C (https=)
SE (1) SE450088B (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4678773A (en) * 1983-08-26 1987-07-07 Chugai Seiyaku Kabushiki Kaisha Antitumor agent
DE3817762A1 (de) * 1988-05-26 1989-11-30 Sanum Kehlbeck Gmbh & Co Kg Immunstimulierendes mittel aus propionibakterien sowie verfahren zur herstellung desselben
IL101410A0 (en) * 1992-03-29 1992-11-15 Era Masis Ltd Formulation for the treatment of cancer
DE19630230A1 (de) * 1996-07-26 1998-01-29 Bayer Ag Herstellung immunstimulierender Mittel auf Basis von Propionibakterien
FR2764802A1 (fr) * 1996-12-24 1998-12-24 Standa Lab Sa Composition adsorbable renfermant des bacteries propioniques susceptible de degager du monoxyde d'azote dans le tube digestif humain ou animal
KR100533576B1 (ko) 1997-08-05 2005-12-05 바이오니취 라이프 사이언시즈 인코포레이티드 세포증식 및 세포사멸 조절용 조성물 및 방법
CN1187043C (zh) 1999-10-19 2005-02-02 明治乳业株式会社 用于防止和改善代谢性骨病的食品材料和包含这些材料的用于代谢性骨病的预防药/治疗药
EP1867718B1 (en) * 1999-12-13 2010-01-20 Bioniche Life Sciences Inc. Therapeutically useful synthetic oligonucleotides
CA2395493C (en) * 1999-12-28 2010-06-22 Bioniche Life Sciences Inc. Hyaluronic acid in the treatment of cancer
GB2623078B (en) * 2022-10-03 2025-04-16 Univ Brunel Prevention and/or treatment of wound infection

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2269962B1 (https=) * 1974-05-06 1978-02-03 Anvar
FR2269961B1 (https=) * 1974-05-06 1978-03-24 Anvar
JPS5215894A (en) * 1975-07-29 1977-02-05 Yuichi Yamamura Process for preparing a substance possessing biological actions
JPS5946206B2 (ja) * 1975-10-08 1984-11-10 （株） 目黒研究所 免疫学的活性を有する非病原性好気性コリネバクテリウム培養物の製造法
JPS52108091A (en) * 1976-03-03 1977-09-10 Kowa Co Production of antiitumor substance
JPS5411233A (en) * 1977-06-28 1979-01-27 Asahi Chem Ind Co Ltd Anitidote
JPS5513204A (en) * 1978-06-28 1980-01-30 Mitsui Toatsu Chem Inc Active compound having delayed allergic activity and anticarcinogenic activity, and its preparation
JPS55114290A (en) * 1979-02-27 1980-09-03 Mitsui Toatsu Chem Inc Substance with antitumorigenic activity, its production and medical preparation

Also Published As

Publication number Publication date
CH661868A5 (de) 1987-08-31
DE3011461C2 (de) 1986-10-30
NO810815L (no) 1982-09-13
FR2505186B1 (https=) 1984-10-12
CA1197798A (en) 1985-12-10
NO162079C (no) 1989-11-01
JPS57165319A (en) 1982-10-12
NL189947C (nl) 1993-09-16
BE888770A (fr) 1981-11-12
SE8101582L (sv) 1982-09-13
NL189947B (nl) 1993-04-16
US4647456A (en) 1987-03-03
DE3011461A1 (de) 1981-10-01
FR2505186A1 (fr) 1982-11-12
ATA118981A (de) 1982-10-15
NL8101452A (nl) 1982-10-18
AT371714B (de) 1983-07-25
NO162079B (no) 1989-07-24
GB2098478B (en) 1985-02-20
GB2098478A (en) 1982-11-24
AU548596B2 (en) 1985-12-19
AU7024281A (en) 1982-11-11
SE450088B (sv) 1987-06-09

Similar Documents

Publication Publication Date Title
Kimura et al. Immunochemotherapy in human lung cancer using the streptococcal agent OK‐432
Rosenberg Immunotherapy of cancer using interleukin 2: current status and future prospects
DK168755B1 (da) Farmaceutisk præparat til diagnose og terapi af tumorer samt til behandling af svækkelser af celle- og humoral-immunforsvar
Milas et al. Corynebacterium granulosum-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice
JPH0355448B2 (https=)
US5316763A (en) Short-term anti-CD3 stimulation of lymphocytes to increase their in vivo acitivity
Burton et al. In vitro induction of tumor-specific immunity. IV. Specific adoptive immunotherapy with cytotoxic T cells induced in vitro to plasmacytoma antigens
Hultborn et al. Irradiation of skin tumours during pure oxygen inhalation
HATTORI et al. Five-year survival rate of gastric cancer patients treated by gastrectomy, large dose of mitomycin-C, and/or allogeneic bone marrow transplantation
Schwarzenberg et al. Human toxicology of BCG applied in cancer immunotherapy
US6726913B1 (en) Treatment of dermal tumors, warts, and viral infections of the respiratory tract in humans using heat-killed P. acnes
CA2383626A1 (en) Treatment of dermal tumors, warts, and viral infections using heat-killed p. acnes
CN110859859A (zh) 一种含有固定细菌的抗肿瘤组合物及其应用
YAMAMURA et al. SUCCESSFUL TREATMENT OF THE PATIENTS WITH MALIGNANT PLEURAL EFFUSION WITH BCG CELL-WALL SKELTEON
Chirigos et al. Pharmacokinetic and therapeutic activity of polyinosinic-polycytidylic acid stabilized with poly-L-lysine in carboxymethylcellulose [poly (I, C)-LC]
Grigg et al. G-CSF stimulated donor granulocyte collections for neutropenic sepsis
UA78215C2 (en) Preparation possessing anticancer, detoxifying, and radioprotection activities
Arika et al. Combination therapy of radiation and Sizofiran (SPG) on the tumor growth and metastasis on squamous-cell carcinoma NR-S1 in syngeneic C3H/He mice
SU1304736A3 (ru) Способ получени противоопухолевого средства
Wilson et al. Dimethyl ether of d-tubocurarine iodide as a curarizing agent in anaesthesia for thoracic surgery
KR850000143B1 (ko) 세포벽표본의 제조방법
CN120478384A (zh) 治疗结直肠癌的方法
HATTORI et al. Combination of non-specific immunopotentiation with Corynebacterium liquefaciens and chemotherapy in tumor-bearing mice
CN107375299A (zh) 一种积雪草酸的新用途及含积雪草酸的抗肿瘤药物组合
CN118987031A (zh) Nk细胞外泌体联合nk细胞在三阴性乳腺癌治疗中的应用